Stock Analysis

Intelligent Bio Solutions First Quarter 2025 Earnings: US$0.70 loss per share (vs US$12.49 loss in 1Q 2024)

NasdaqCM:INBS
Source: Shutterstock

Intelligent Bio Solutions (NASDAQ:INBS) First Quarter 2025 Results

Key Financial Results

  • Revenue: US$872.3k (up 9.6% from 1Q 2024).
  • Net loss: US$2.69m (loss widened by 11% from 1Q 2024).
  • US$0.70 loss per share.
earnings-and-revenue-history
NasdaqCM:INBS Earnings and Revenue History November 13th 2024

All figures shown in the chart above are for the trailing 12 month (TTM) period

Intelligent Bio Solutions shares are up 25% from a week ago.

Risk Analysis

It's necessary to consider the ever-present spectre of investment risk. We've identified 6 warning signs with Intelligent Bio Solutions (at least 5 which can't be ignored), and understanding them should be part of your investment process.

New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.